Recommendations
| Recommendation . | Remarks . |
|---|---|
| Recommendation 3. The ASH guideline panel suggests that outpatient anticoagulant thromboprophylaxis not be used in patients with COVID-19 who are being discharged from the hospital and who do not have suspected or confirmed VTE or another indication for anticoagulation (conditional recommendation based on low certainty in the evidence about effects ⊕◯◯◯). | An individualized assessment of the patient’s risk of thrombosis and bleeding and shared decision making are important when deciding whether to use postdischarge thromboprophylaxis. Prospectively validated risk assessment models to estimate thrombotic and bleeding risk in patients with COVID-19 after hospital discharge are not available. The panel acknowledged that postdischarge thromboprophylaxis may be reasonable in patients judged to be at high risk of thrombosis and low risk of bleeding. |
| Recommendation . | Remarks . |
|---|---|
| Recommendation 3. The ASH guideline panel suggests that outpatient anticoagulant thromboprophylaxis not be used in patients with COVID-19 who are being discharged from the hospital and who do not have suspected or confirmed VTE or another indication for anticoagulation (conditional recommendation based on low certainty in the evidence about effects ⊕◯◯◯). | An individualized assessment of the patient’s risk of thrombosis and bleeding and shared decision making are important when deciding whether to use postdischarge thromboprophylaxis. Prospectively validated risk assessment models to estimate thrombotic and bleeding risk in patients with COVID-19 after hospital discharge are not available. The panel acknowledged that postdischarge thromboprophylaxis may be reasonable in patients judged to be at high risk of thrombosis and low risk of bleeding. |